Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Jena, Friedrich-Schiller-Universität Jena, Dissertation, 2019
- Schlagwort
-
Phosphatases
Tyrosine
- Ereignis
-
Veröffentlichung
- (wo)
-
Jena
- (wer)
-
Friedrich-Schiller-Universität Jena
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.22032/dbt.38319
- URN
-
urn:nbn:de:gbv:27-dbt-20190314-1325229
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kresinsky, Anne
- Müller, Jörg Paul
- Böhmer, Frank-D.
- Müller-Tidow, Carsten
- Friedrich-Schiller-Universität Jena
Entstanden
- 2019
Ähnliche Objekte (12)
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma
Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes
Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia
Myeloische Neoplasien
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
FLT3-ITD regulated miRs in AML
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma
Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes
Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia
Myeloische Neoplasien
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
FLT3-ITD regulated miRs in AML
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma
Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes
Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia
Myeloische Neoplasien
S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression
FLT3-ITD regulated miRs in AML
RSK1 dependency in FLT3-ITD acute myeloid leukemia